Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Validity and reliability of the FSS in Greek MS patients.
Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders.
Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Errors in the Byline, Author Affiliations, and Author Contributions in: Long-term Follow-up of Acute Partial Transverse Myelitis.
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.
Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.
The association between multiple sclerosis and fracture risk.
The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Commentary on Pique et al.'s paper entitled: Peripheral late reactivation of a previously typical monofocal Balo's concentric sclerosis lesion.
Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis.
Carbon Monoxide and Central Nervous System: Challenges and Achievements.
Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment : Case report and review of the literature.
Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review.
Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.
Late-onset multiple sclerosis in South-East wales.
The gateway theory: bridging neural and immune interactions in the CNS.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Remyelination strategies in multiple sclerosis: a critical reflection.
Obesity and brain inflammation: a focus on multiple sclerosis.
Metaboreflex activity in multiple sclerosis patients.

Pages